Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by knicksman

T.DCM

RE:RE:RE:RE:RE:Some good news finally

I think it's be fair to assume that the business was won with an...

October 4, 2017

RDIAF

RE:Looks like shareholders are going to be approached...

This has been a complete sh!tshow. Stakeholders will be offered a price to...

September 25, 2017

T.DCM

RE:Volume??

The company is in full turnaround mode. It'll likely be a grind, but I...

September 6, 2017

T.DCM

RE:Can't break $1.35

You're right. My sense is that investors who purchased the raise may feel...

August 15, 2017

T.DCM

RE:Headline focused?

The stock is so cheap. Do the math. Much worse has been priced-in. The...

August 9, 2017

T.DCM

RE:A "Decent" Quarter Could Launch this Stock

We got a decent Q2. Revenues were $73.1 million and EBITDA was $4.3 million...

August 8, 2017

T.DCM

RE:RE:RE:Q2 results out next Monday..

All I was saying is that the company likely did NOT have issues regarding its...

August 4, 2017

T.DCM

A "Decent" Quarter Could Launch this Stock

The company is scheduled to report on Tuesday after the close. Here are my...

August 4, 2017

T.DCM

RE:Q2 results out next Monday..

Covenant issues are not even a remote concern following the company's...

August 4, 2017

T.DCM

Best (High-Risk) Opportunity

Last year, the company was in the early stage of its transformation. However,...

July 17, 2017

T.STC

RE:RE:Galea just filled on SEDI

I would argue that his selling and the (undisciplined) behaviour reflected in...

July 12, 2017

T.DCM

RE:RE:Please give some insight

A couple of corrections. Guidance is for $22 million to $26 million. And...

July 12, 2017

T.STC

RE:Don't believe...

Dude. Get off this board.

July 11, 2017

T.STC

RE:Iceberg

It's very aggressive selling. But I agree, that means discounted shares...

July 11, 2017

T.DCM

RE:RE:RE:RE:RE:RE:debentures

Let me guess -- all your other stock picks are perfect?! Base your stock...

July 10, 2017

T.STC

RE:RE:RE:RE:500k share dump from TD

I highly doubt the seller is the previous owner of the most recent...

July 5, 2017

T.STC

RE:500k share dump from TD

There aren't many shareholders (one), of public record, that own enough...

July 5, 2017

RDIAF

RE:RE:RE:New Hearing date, Oct 31, 2017.

I tend to agree. Everything should be (largely) in place by the end of August...

July 4, 2017

T.STC

RE:RE:RE:Sellers

I believe TD represents the large seller. There have been other sellers as...

June 28, 2017

T.STC

RE:Sellers

A (single) seller looks to be liquidating his position. Doesn't mean...

June 27, 2017

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »